Cognex Corporation CGNX
Composite 60/100; the shares have moved about 49% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 17/100 — a strong mark against it.
Balance-sheet strength ranks 93/100 — a strong point in its favour. Growth ranks 68/100 — a moderate point in its favour. Quality ranks 66/100 — a moderate point in its favour.
Valuation ranks 17/100 — a strong mark against it. Income ranks 38/100 — a slight mark against it.
What the company does Cognex designs and sells machine-vision systems—cameras, sensors, and software—that automate inspection, guidance, and tracking in factories and distribution centers. Its products (In-Sight, DataMan, VisionPro, OneVision) target discrete manufacturing, automotive, electronics, and e-commerce.
Key financials Revenue grew 24.3% and EPS 122.3% in the latest period. Margins remain strong: gross 68.0%, operating 22.3%, net 13.6%. Returns are solid: ROE 9.8%, ROA 6.2%, ROCE 11.9%. Balance sheet is pristine: debt/equity 0.05, current ratio 3.64, net debt/EBITDA –0.98.
Stock health Momentum is robust: +17.16% (3m), +60.81% (6m), +84.04% (12m), though –14.08% below its 52-week high. Quality pillar 61.2/100, growth 85.8, strength 95.4, valuation 15.4, momentum 77.5, income 46.2.
Price vs fair value CGNX trades at a PREMIUM of 56.10% to our fair-value estimate of 27.47 and at a discount of 23.30% to the 12-month target of 77.21. - Analysts rate valuation at the 15.4th percentile (Valuation percentile 15.4/100). - Forward P/E of 33.90 and P/E of 73.00 sit well above long-run medians (Fwd P/E 33.90, P/E 73.00). - Recent article explicitly excludes CGNX from mid-cap coverage (3 Mid-Cap Stocks We Keep Off Our Radar).
Looking forward OneVision’s cloud-based AI platform and continued factory automation tailwinds could support sustained growth. Analysts expect 12-month upside to 77.21, implying a potential rerating if adoption accelerates.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.